JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeuchi, K.
Right arrow Articles by Suzuki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeuchi, K.
Right arrow Articles by Suzuki, K.

Vol. 297, Issue 3, 1160-1165, June 2001

Adaptive Gastric Cytoprotection Is Mediated by Prostaglandin EP1 Receptors: A Study Using Rats and Knockout Mice

Koji Takeuchi, Hideo Araki, Masakazu Umeda, Yusaku Komoike and Keizo Suzuki

Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto, Japan

Endogenous prostaglandins (PGs) play a central role in adaptive cytoprotection induced in the stomach by mild irritants. In the present study, we used taurocholate (TC) as a mild irritant in both rats and EP-receptor knockout mice, and examined which EP receptor is responsible for the adaptive gastric cytoprotection. Gastric lesions were induced by p.o. administration of HCl/ethanol (60% ethanol in 150 mM HCl). TC (5-20 mM) or PGE2 was administered p.o. 30 min before HCl/ethanol. HCl/ethanol-induced gastric lesions were dose dependently prevented by TC, and the effect at 20 mM was equivalent to that induced by PGE2 at 0.3 mg/kg. The protective effect of TC was significantly attenuated by indomethacin as well as ONO-AE-829, the EP1 antagonist, but not by either NS-398, the selective cyclooxygenase (COX)-2 inhibitor, or chemical ablation of capsaicin-sensitive sensory neurons. Likewise, the protective action of PGE2 was also antagonized by ONO-AE-829 but not chemical deafferentation. TC significantly increased PGE2 contents in the stomach, with or without chemical deafferentation, and this effect was blocked in the presence of indomethacin but not NS-398 or ONO-AE-829. TC increased the mucosal PGE2 contents similarly in both wild-type and knockout mice lacking EP1 or EP3 receptors, yet the protective action of TC against HCl/ethanol was observed in both wild-type and EP3 receptor knockout mice, but not in mice lacking EP1 receptors. The present findings confirmed a role for endogenous PGE2 produced by COX-1 in adaptive gastric cytoprotection and suggested that this action is mediated by activation of EP1-receptors but not associated with capsaicin-sensitive afferent neurons.

0022-3565/01/2973-1160$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
O. T. Starodub, E. S. Demitrack, H. K. Baumgartner, and M. H. Montrose
Disruption of the Cox-1 gene slows repair of microscopic lesions in the mouse gastric epithelium
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C223 - C232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Hatazawa, A. Tanaka, M. Tanigami, K. Amagase, S. Kato, Y. Ashida, and K. Takeuchi
Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G788 - G797.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Takeuchi, A. Tanaka, S. Kato, E. Aihara, and K. Amagase
Effect of (S)-4-(1-(5-Chloro-2-(4-fluorophenyoxy)benzamido)ethyl) Benzoic Acid (CJ-42794), a Selective Antagonist of Prostaglandin E Receptor Subtype 4, on Ulcerogenic and Healing Responses in Rat Gastrointestinal Mucosa
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 903 - 912.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Aritake, Y. Kado, T. Inoue, M. Miyano, and Y. Urade
Structural and Functional Characterization of HQL-79, an Orally Selective Inhibitor of Human Hematopoietic Prostaglandin D Synthase
J. Biol. Chem., June 2, 2006; 281(22): 15277 - 15286.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. Tsutsumi, S. Mima, W. Tomisato, T. Hoshino, T. Tsuchiya, and T. Mizushima
Molecular Mechanism of Adaptive Cytoprotection Induced by Ethanol in Human Gastric Cells
Experimental Biology and Medicine, October 1, 2003; 228(9): 1089 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Hoshino, S. Tsutsumi, W. Tomisato, H.-J. Hwang, T. Tsuchiya, and T. Mizushima
Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation
J. Biol. Chem., April 4, 2003; 278(15): 12752 - 12758.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Takeuchi, S. Kato, M. Takeeda, Y. Ogawa, M. Nakashima, and M. Matsumoto
Facilitation by Endogenous Prostaglandins of Capsaicin-Induced Gastric Protection in Rodents through EP2 and IP Receptors
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1055 - 1062.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.